San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Hims & Hers Health, Inc. sees 38% YoY subscriber growth, driven by 70% choosing personalized treatments. Click for my updated ...

Hims & Hers (HIMS) defends recovery with personalized healthcare adoption, GLP-1 partnerships, and profit growth. Click here to read my most recent analysis.

A nurse in a telehealth platform talking with a patient on video call for consultation. Hims & Hers Health, Inc. (NYSE:HIMS) is not on our list of 30 Most Popular Stocks Among Hedge Funds.

The franchise's revitalization led to an NHL record sale price of $1.8 billion in October 2024 to a group of investors led by Doug Ostrover and Marc Lipschultz of Blue Owl Capital.

“The name of the game is streaming and online content, and the OnlyFans $8 billion valuation could exceed the price tag of some legacy Hollywood studios, speaking to a new world for the industry ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $1.0 to $100.0 for Hims & Hers Health over the last 3 months.

Expert Opinions on Hims & Hers Health 2 market experts have recently issued ratings for this stock, with a consensus target price of $52.5. Turn $1000 into $1270 in just 20 days?

One healthcare player that is (so far) outmaneuvering investor trepidation throughout 2025 is telemedicine company Hims & Hers Health (NYSE: HIMS). Its share price is up 138% in 2025 (as of June 17).

French customers will be be able to watch live feeds, including sports, from TF1’s channels, and stream the broadcaster’s shows on demand from next summer.

Dozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon.